Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1950 1
1951 1
1953 2
1954 3
1956 1
1957 1
1958 2
1959 2
1960 2
1961 1
1962 1
1963 1
1964 2
1965 3
1968 1
1969 3
1970 2
1971 2
1972 3
1973 6
1974 3
1975 3
1976 7
1977 3
1978 3
1979 1
1980 1
1981 7
1982 3
1983 6
1984 11
1985 4
1986 5
1987 8
1988 4
1989 5
1990 3
1991 3
1992 1
1993 2
1994 4
1996 4
1997 2
1998 1
1999 2
2000 9
2001 3
2002 1
2003 2
2004 2
2005 1
2006 4
2007 2
2008 2
2009 3
2011 1
2012 5
2013 2
2014 4
2015 2
2016 2
2017 1
2018 2
2019 2
2020 2
2021 3
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.
Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B; American Brachytherapy Society. Viswanathan AN, et al. Brachytherapy. 2012 Jan-Feb;11(1):47-52. doi: 10.1016/j.brachy.2011.07.002. Brachytherapy. 2012. PMID: 22265437 Free PMC article.
PURPOSE: This report presents an update to the American Brachytherapy Society (ABS) high-dose-rate (HDR) brachytherapy guidelines for locally advanced cervical cancer. METHODS: Members of the ABS with expertise in cervical cancer formulated updated guidelines for HDR brach …
PURPOSE: This report presents an update to the American Brachytherapy Society (ABS) high-dose-rate (HDR) brachytherapy guidelines for locall …
The epidemiology, diagnosis, and treatment of Barrett's carcinoma.
Labenz J, Koop H, Tannapfel A, Kiesslich R, Hölscher AH. Labenz J, et al. Dtsch Arztebl Int. 2015 Mar 27;112(13):224-33; quiz 234. doi: 10.3238/arztebl.2015.0224. Dtsch Arztebl Int. 2015. PMID: 25869347 Free PMC article. Review.
In stages cT3/4, the prognosis can be improved with neo-adjuvant chemo - therapy or combined radiotherapy and chemotherapy. Metastatic Barrett's carcinoma can be treated by endoscopic, chemotherapeutic, radiotherapeutic, and palliative methods. CONCLUSION: Early …
In stages cT3/4, the prognosis can be improved with neo-adjuvant chemo - therapy or combined radiotherapy and chemotherapy. Metastati …
Current and future treatment options for esophageal cancer in the elderly.
Bollschweiler E, Plum P, Mönig SP, Hölscher AH. Bollschweiler E, et al. Expert Opin Pharmacother. 2017 Jul;18(10):1001-1010. doi: 10.1080/14656566.2017.1334764. Epub 2017 Jun 7. Expert Opin Pharmacother. 2017. PMID: 28540761 Review.
The main points of interest were treatment options for patients with Barrett's esophagus or early carcinoma, advanced tumor stages, and inoperable cancer. Expert opinion: The incidence of esophageal cancer has been increasing over the past thirty years, with a rapid …
The main points of interest were treatment options for patients with Barrett's esophagus or early carcinoma, advanced tumor st …
Management of Locally Advanced Carcinoma Oesophagus with Radiation/Chemoradiation: Single Institute Experience.
Kumaran D, John S, Isiah R, Das S. Kumaran D, et al. J Gastrointest Cancer. 2016 Sep;47(3):313-7. doi: 10.1007/s12029-016-9825-5. J Gastrointest Cancer. 2016. PMID: 27146042 Review.
This study brings the role of radiation therapy in terms of loco-regional and distant relapse. This study characterizes demographic characteristics, treatment modality and the impact of these on recurrence-free survival of locally advanced carcinoma oesophagu …
This study brings the role of radiation therapy in terms of loco-regional and distant relapse. This study characterizes demographic c …
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma.
Katayama S, Mori K, Schuettfort VM, Pradere B, Mostafaei H, Quhal F, Rajwa P, Motlagh RS, Laukhtina E, Moschini M, Grossmann NC, Araki M, Teoh JY, Rouprêt M, Margulis V, Enikeev D, Karakiewicz PI, Abufaraj M, Compérat E, Nasu Y, Shariat SF. Katayama S, et al. Eur Urol Focus. 2022 May;8(3):761-768. doi: 10.1016/j.euf.2021.05.002. Epub 2021 May 27. Eur Urol Focus. 2022. PMID: 34053904 Free article. Review.
BACKGROUND: Among various clinicopathologic factors used to identify low-risk upper tract urothelial carcinoma (UTUC), tumor grade and stage are of utmost importance. The clinical value added by inclusion of other risk factors remains unproven. ...A decision-making algorit …
BACKGROUND: Among various clinicopathologic factors used to identify low-risk upper tract urothelial carcinoma (UTUC), tumor grade an …
Endoscopic Diagnosis and Treatment of Esophageal Squamous Cell Carcinoma.
Zhang R, Lau LHS, Wu PIC, Yip HC, Wong SH. Zhang R, et al. Methods Mol Biol. 2020;2129:47-62. doi: 10.1007/978-1-0716-0377-2_5. Methods Mol Biol. 2020. PMID: 32056169
Esophageal squamous cell carcinoma (ESCC) is a deadly disease, partly because it is often diagnosed late in disease stage. An accurate early diagnosis by endoscopy could detect advanced carcinoma as well as curable dysplasia and early ESCC. This could save pa …
Esophageal squamous cell carcinoma (ESCC) is a deadly disease, partly because it is often diagnosed late in disease stage. An accurat …
Practical management of everolimus-related toxicities in patients with advanced solid tumors.
Grünwald V, Weikert S, Pavel ME, Hörsch D, Lüftner D, Janni W, Geberth M, Weber MM. Grünwald V, et al. Onkologie. 2013;36(5):295-302. doi: 10.1159/000350625. Epub 2013 Apr 5. Onkologie. 2013. PMID: 23689226 Review.
Everolimus is an orally administered inhibitor of the mammalian target of rapamycin (mTOR), an intracellular protein kinase downstream of the phosphatidylinositol 3-kinase/AKT pathway involved in key components of tumorigenesis, including cell growth, proliferation, and angiogene …
Everolimus is an orally administered inhibitor of the mammalian target of rapamycin (mTOR), an intracellular protein kinase downstream of th …
Neoadjuvant treatment intensification or adjuvant chemotherapy for locally advanced carcinoma rectum: The optimum treatment approach remains unresolved.
Mallick S, Benson R, Haresh KP, Rath GK. Mallick S, et al. J Egypt Natl Canc Inst. 2015 Dec;27(4):179-85. doi: 10.1016/j.jnci.2015.05.003. Epub 2015 Jun 10. J Egypt Natl Canc Inst. 2015. PMID: 26071798 Free article. Review.
BACKGROUND: Rectal carcinoma [RC] is often managed with preoperative radiotherapy or radio-chemotherapy followed by total mesorectal excision (TME). ...METHODOLOGY: We reviewed the recent land mark trials to find a road map in the management of locally advanced rect …
BACKGROUND: Rectal carcinoma [RC] is often managed with preoperative radiotherapy or radio-chemotherapy followed by total mesorectal …
Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status.
Afqir S, Ismaili N, Errihani H. Afqir S, et al. J Cancer Res Ther. 2009 Jan-Mar;5(1):3-7. doi: 10.4103/0973-1482.48763. J Cancer Res Ther. 2009. PMID: 19293481 Free article. Review.
Nasopharyngeal carcinoma (NPC) differs from other head and neck cancers in its epidemiology, natural behavior and, particularly, in the therapeutic considerations. ...To identify the studies mentioned in this article, we searched the MEDLINE database, and abstracts …
Nasopharyngeal carcinoma (NPC) differs from other head and neck cancers in its epidemiology, natural behavior and, particularly, in t …
Management of advanced carcinoma of the base of tongue.
Karatzanis AD, Psychogios G, Mantsopoulos K, Zenk J, Velegrakis GA, Waldfahrer F, Iro H. Karatzanis AD, et al. J Surg Oncol. 2012 Nov;106(6):713-8. doi: 10.1002/jso.23135. Epub 2012 Apr 24. J Surg Oncol. 2012. PMID: 22532105
This study aims to evaluate the experience of a single head and neck oncology center in the management of advanced stage base-of-tongue cancer. METHODS: A retrospective evaluation of cases primarily treated for stage III/IV(A-B) base-of-tongue carcinoma, between 198 …
This study aims to evaluate the experience of a single head and neck oncology center in the management of advanced stage base-of-tong …
196 results